Please provide your email address to receive an email when new articles are posted on . Patients were given a single dose of 1,000mg of IV iron or placebo. Researchers found no mean between-group ...

In a study, IV iron was associated with twice the risk for infections in CKD. SAN DIEGO—Non-dialysis chronic kidney disease (CKD) patients receiving intravenous (IV) iron therapy may have increased ...

Randomized controlled trial finds no significant difference between high- and low-dose intravenous iron with respect to mortality, non-fatal cardiovascular outcomes, and infection. SAN ...

This article is part of a special supplement published by Nephrology News & Issues in the February 2014 issue entitled, "Iron therapy and a quarter century of ESAs: What have we learned?" Management ...

Iron deficiency anemia common but underdiagnosed and undertreated in patients with gastrointestinal conditions; high-dose intravenous iron an effective treatment option CHICAGO--(BUSINESS ...

None of the IV iron products were found to be associated with an increased risk of adverse or serious adverse events compared with oral iron The safety profiles of various intravenous (IV) iron ...

Intravenous iron associated with significant reduction in 30-day postoperative mortality and morbidity compared with RBC transfusion. HealthDay News — For patients with preoperative iron deficiency ...

Intravenous iron therapy is effective for rapid iron repletion, especially when oral supplements are inadequate or poorly tolerated. Tailoring IV iron formulation and dosing to individual patient ...

A global study led by researchers at The University of Western Australia has addressed the rising use of intravenous iron therapy in anemic patients during major surgery and found there is little ...

Injectafer, made by Daiichi Sankyo, is a ferric carboxymaltose injection treatment for iron deficiency in adult patients with heart failure to improve exercise capacity, according to a June 5 company ...